81 related articles for article (PubMed ID: 21596848)
1. Risk stratification of intermediate-risk acute myeloid leukemia: integrative analysis of a multitude of gene mutation and gene expression markers.
Rockova V; Abbas S; Wouters BJ; Erpelinck CA; Beverloo HB; Delwel R; van Putten WL; Löwenberg B; Valk PJ
Blood; 2011 Jul; 118(4):1069-76. PubMed ID: 21596848
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a promising 5-gene prognostic model for pediatric acute myeloid leukemia.
Tao Y; Wei L; Shiba N; Tomizawa D; Hayashi Y; Ogawa S; Chen L; You H
Mol Biomed; 2024 Jan; 5(1):1. PubMed ID: 38163849
[TBL] [Abstract][Full Text] [Related]
3. RNA and protein expression of herpesvirus entry mediator (HVEM) is associated with molecular markers, immunity-related pathways and relapse-free survival of patients with AML.
Lichtenegger FS; Kondla I; Krempasky M; Weber AL; Herold T; Krupka C; Spiekermann K; Schneider S; Büchner T; Berdel WE; Wörmann BJ; Hiddemann W; Subklewe M
Cancer Immunol Immunother; 2015 Dec; 64(12):1505-15. PubMed ID: 26377688
[TBL] [Abstract][Full Text] [Related]
4. Stellae-123 gene expression signature improved risk stratification in taiwanese acute myeloid leukemia patients.
Wang YH; Orgueira AM; Lin CC; Yao CY; Lo MY; Tsai CH; de la Fuente Burguera A; Hou HA; Chou WC; Tien HF
Sci Rep; 2024 May; 14(1):11064. PubMed ID: 38744924
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia.
Mrózek K; Marcucci G; Nicolet D; Maharry KS; Becker H; Whitman SP; Metzeler KH; Schwind S; Wu YZ; Kohlschmidt J; Pettenati MJ; Heerema NA; Block AW; Patil SR; Baer MR; Kolitz JE; Moore JO; Carroll AJ; Stone RM; Larson RA; Bloomfield CD
J Clin Oncol; 2012 Dec; 30(36):4515-23. PubMed ID: 22987078
[TBL] [Abstract][Full Text] [Related]
6. Intermediate-risk acute myeloid leukemia therapy: current and future.
Döhner K; Paschka P
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):34-43. PubMed ID: 25696832
[TBL] [Abstract][Full Text] [Related]
7. The Prognostic Relevance of BAALC and ERG Expression Levels in Cytogenetically Normal Pediatric Acute Myeloid Leukemia.
Aref S; Al Khodary T; Zeed TA; El Sadiek A; El Menshawy N; Al Ashery R
Indian J Hematol Blood Transfus; 2015 Mar; 31(1):21-8. PubMed ID: 25548440
[TBL] [Abstract][Full Text] [Related]
8. Acute myeloid leukemia: 2013 update on risk-stratification and management.
Estey EH
Am J Hematol; 2013 Apr; 88(4):318-27. PubMed ID: 23526416
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of CEBPA mutational subgroups in adult AML.
Georgi JA; Stasik S; Kramer M; Meggendorfer M; Röllig C; Haferlach T; Valk P; Linch D; Herold T; Duployez N; Taube F; Middeke JM; Platzbecker U; Serve H; Baldus CD; Muller-Tidow C; Haferlach C; Koch S; Berdel WE; Woermann BJ; Krug U; Braess J; Hiddemann W; Spiekermann K; Boertjes EL; Hills RK; Burnett A; Ehninger G; Metzeler K; Rothenberg-Thurley M; Dufour A; Dombret H; Pautas C; Preudhomme C; Fenwarth L; Bornhäuser M; Gale R; Thiede C
Leukemia; 2024 Feb; 38(2):281-290. PubMed ID: 38228680
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic/prognostic roles and biological function of the IFIT family members in acute myeloid leukemia.
Zhao Y; Zhang Y; Lu W; Sun R; Guo R; Cao X; Liu X; Lyu C; Zhao M
BMC Med Genomics; 2023 Nov; 16(1):296. PubMed ID: 37980495
[TBL] [Abstract][Full Text] [Related]
11. Verification of prognostic expression biomarkers is improved by examining enriched leukemic blasts rather than mononuclear cells from acute myeloid leukemia patients.
Pogosova-Agadjanyan EL; Hua X; Othus M; Appelbaum FR; Chauncey TR; Erba HP; Fitzgibbon MP; Jenkins IC; Fang M; Lee SC; Moseley A; Naru J; Radich JP; Smith JL; Willborg BE; Willman CL; Wu F; Meshinchi S; Stirewalt DL
Biomark Res; 2023 Mar; 11(1):31. PubMed ID: 36927800
[TBL] [Abstract][Full Text] [Related]
12. The expression level of Neuronal Calcium Sensor 1 can predict the prognosis of cytogenetically normal AML.
Zhang W; Wang J; Li W; Liu X; Zhao Y; Yang P; Zhu M; Hu K; Li S; Dong G; Yan C; He X; Zhang X; Jing H
Pharmacogenomics J; 2023 Jul; 23(4):89-94. PubMed ID: 36918700
[TBL] [Abstract][Full Text] [Related]
13. A validation study of potential prognostic DNA methylation biomarkers in patients with acute myeloid leukemia using a custom DNA methylation sequencing panel.
Šestáková Š; Cerovská E; Šálek C; Kundrát D; Ježíšková I; Folta A; Mayer J; Ráčil Z; Cetkovský P; Remešová H
Clin Epigenetics; 2022 Feb; 14(1):22. PubMed ID: 35148810
[TBL] [Abstract][Full Text] [Related]
14. The retinoic acid receptor co-factor NRIP1 is uniquely upregulated and represents a therapeutic target in acute myeloid leukemia with chromosome 3q rearrangements.
Grasedieck S; Cabantog A; MacPhee L; Im J; Ruess C; Demir B; Sperb N; Rücker FG; Döhner K; Herold T; Pollack JR; Bullinger L; Rouhi A; Kuchenbauer F
Haematologica; 2022 Aug; 107(8):1758-1772. PubMed ID: 34854277
[TBL] [Abstract][Full Text] [Related]
15. Establishment of Prognosis Model in Acute Myeloid Leukemia Based on Hypoxia Microenvironment, and Exploration of Hypoxia-Related Mechanisms.
Zhong J; Wu H; Bu X; Li W; Cai S; Du M; Gao Y; Ping B
Front Genet; 2021; 12():727392. PubMed ID: 34777463
[TBL] [Abstract][Full Text] [Related]
16. IDH2 mutations in patients with normal karyotype AML predict favorable responses to daunorubicin, cytarabine and cladribine regimen.
Libura M; Bialopiotrowicz E; Giebel S; Wierzbowska A; Roboz GJ; Piatkowska-Jakubas B; Pawelczyk M; Gorniak P; Borg K; Wojtas M; Florek I; Matiakowska K; Jazwiec B; Solarska I; Noyszewska-Kania M; Piechna K; Zawada M; Czekalska S; Salamanczuk Z; Karabin K; Wasilewska K; Paluszewska M; Urbanowska E; Gajkowska-Kulik J; Semenczuk G; Rybka J; Wrobel T; Ejduk A; Kata D; Grosicki S; Robak T; Pluta A; Kominek A; Piwocka K; Pyziak K; Sroka-Porada A; Wrobel A; Przybylowicz A; Wojtaszewska M; Lewandowski K; Gil L; Piekarska A; Knopinska W; Bolkun L; Warzocha K; Kuliczkowski K; Sacha T; Basak G; Jedrzejczak WW; Holowiecki J; Juszczynski P; Haus O
Sci Rep; 2021 May; 11(1):10017. PubMed ID: 33976256
[TBL] [Abstract][Full Text] [Related]
17. A Novel Role for Brain and Acute Leukemia Cytoplasmic (BAALC) in Human Breast Cancer Metastasis.
Birgersson M; Chi M; Miller C; Brzozowski JS; Brown J; Schofield L; Taylor OG; Pearsall EA; Hewitt J; Gedye C; Lincz LF; Skelding KA
Front Oncol; 2021; 11():656120. PubMed ID: 33968759
[TBL] [Abstract][Full Text] [Related]
18. AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: a SWOG report.
Pogosova-Agadjanyan EL; Moseley A; Othus M; Appelbaum FR; Chauncey TR; Chen IL; Erba HP; Godwin JE; Jenkins IC; Fang M; Huynh M; Kopecky KJ; List AF; Naru J; Radich JP; Stevens E; Willborg BE; Willman CL; Wood BL; Zhang Q; Meshinchi S; Stirewalt DL
Biomark Res; 2020; 8():29. PubMed ID: 32817791
[TBL] [Abstract][Full Text] [Related]
19. HMGA Proteins in Hematological Malignancies.
Minervini A; Coccaro N; Anelli L; Zagaria A; Specchia G; Albano F
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32503270
[TBL] [Abstract][Full Text] [Related]
20. Expression Pattern and Prognostic Significance of
Marjanovic I; Karan-Djurasevic T; Kostic T; Virijevic M; Suvajdzic-Vukovic N; Pavlovic S; Tosic N
Indian J Hematol Blood Transfus; 2020 Apr; 36(2):292-299. PubMed ID: 32425380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
